International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Vitamin C Supplementation and Sputum Conversion in Pulmonary Tuberculosis Patients: A Randomized Controlled Study

Article Information

Volume / Issue7 / 3 (July-August 2026)
Pages230-235
AccessOpen Access

Publication Timeline

  • Received15 June 2026
  • Accepted13 July 2026
  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Background: Pulmonary tuberculosis (TB) patients frequently present with compromised nutritional and antioxidant status, which may impair immune clearance of Mycobacterium tuberculosis. Vitamin C (ascorbic acid) has antioxidant and immune-supportive properties and has been proposed as a low-cost adjunct to standard anti-tuberculosis treatment (ATT).
Objective: To evaluate the effect of vitamin C supplementation, given alongside standard ATT, on the rate of acid-fast bacilli (AFB) sputum smear conversion in newly diagnosed pulmonary TB patients during the intensive phase of treatment.
Methods: A randomized, parallel-group study was conducted in 80 newly diagnosed, sputum-smear-positive, ATT-naïve pulmonary TB patients aged 20–65 years. Participants were allocated to receive either vitamin C (1000 mg/day) plus standard ATT (n=40) or placebo plus standard ATT (n=40). Sputum AFB smears were examined every two weeks for two months. Categorical outcomes were compared using the chi-square test; continuous outcomes (serum vitamin C levels) were compared using an independent-samples t-test. Significance was set at P<0.05.
Results: All 40 patients (100%) in the vitamin C group achieved sputum conversion within the first month, compared with 8 of 40 (20%) in the placebo group; the remaining placebo patients converted in the second month. The difference in conversion rate between groups was statistically significant (P<0.05). Mean serum vitamin C levels rose substantially more in the vitamin C group than in the placebo group over the study period.
Conclusion: Vitamin C supplementation during the intensive phase of ATT was associated with significantly faster AFB sputum conversion in pulmonary TB patients. Given its low cost and mild side-effect profile, vitamin C may be a useful, inexpensive adjunct to standard TB treatment, though confirmation in larger, multi-centric trials is warranted.
 

References

  1. World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization; 2025. [Google Scholar][Crossref]
  2. Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition & tuberculosis in India: situation analysis & the way forward. Indian J Med Res. 2016;144(1):11-20. doi:10.4103/0971-5916.193278. [Google Scholar][Crossref]
  3. Vilchèze C, Hartman T, Weinrick B, Jacobs WR Jr. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction. Nat Commun. 2013;4:1881. doi:10.1038/ncomms2898. [Google Scholar][Crossref]
  4. Vilchèze C, Kim J, Jacobs WR Jr. Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line tuberculosis drugs isoniazid and rifampin in mice. Antimicrob Agents Chemother. 2018;62(4):e02165-17. doi:10.1128/AAC.02165-17. [Google Scholar][Crossref]
  5. Sikri K, Duggal P, Kumar C, et al. Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs. Redox Biol. 2018;15:452 -466. doi:10.1016/j.redox.2017.12.020. [Google Scholar][Crossref]
  6. Susanto L, Siregar Y, Kusumawati L. Vitamin C supplementation improve the sputum conversion culture rate in pulmonary tuberculosis treatment while rifampicin susceptible. IOP Conf Ser Earth Environ Sci. 2018;125:012140. doi:10.1088/1755 -1315/125/1/012140. [Google Scholar][Crossref]
  7. Bozonet SM, Carr AC, Pullar JM, Vissers MCM. Enhanced human neutrophil vitamin C status, chemotaxis and oxidant generation following dietary supplementation with vitamin C-rich SunGold kiwifruit. Nutrients. 2015;7(4):2574 -2588. doi:10.3390/nu7042574. [Google Scholar][Crossref]
  8. Vijayamalini M, Manoharan S. Lipid peroxidation, vitamins C, E and reduced glutathione levels in patients with pulmonary tuberculosis. Cell Biochem Funct. 2004;22(1):19-22. doi:10.1002/cbf.1039. [Google Scholar][Crossref]
  9. Chang SW, Pan WS, Lozano Beltran D, et al. Gut hormones, appetite suppression and cachexia in patients with pulmonary TB. PLoS One. 2013;8(1):e54564. doi:10.1371/journal.pone.0054564. [Google Scholar][Crossref]

How to Cite

Bhat, D., Gupta, S., Rana, R., & Gautam, V. (2026). Vitamin C Supplementation and Sputum Conversion in Pulmonary Tuberculosis Patients: A Randomized Controlled Study. International Journal of Medical and All Body Health Research, 7(3), 230-235. https://doi.org/10.54660/IJMBHR.2026.7.3.230-235

Bhat, Dhananjay, et al. "Vitamin C Supplementation and Sputum Conversion in Pulmonary Tuberculosis Patients: A Randomized Controlled Study." International Journal of Medical and All Body Health Research, vol. 7, no. 3, 2026, pp. 230-235. https://doi.org/10.54660/IJMBHR.2026.7.3.230-235.

Bhat, D., Gupta, S., Rana, R. and Gautam, V. (2026) 'Vitamin C Supplementation and Sputum Conversion in Pulmonary Tuberculosis Patients: A Randomized Controlled Study', International Journal of Medical and All Body Health Research, 7(3), pp. 230-235. doi: 10.54660/IJMBHR.2026.7.3.230-235.

Bhat D, Gupta S, Rana R, Gautam V. Vitamin C Supplementation and Sputum Conversion in Pulmonary Tuberculosis Patients: A Randomized Controlled Study. International Journal of Medical and All Body Health Research. 2026;7(3):230-235. doi:10.54660/IJMBHR.2026.7.3.230-235

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.